GenAI Set to Contribute $100 Billion in Healthcare Savings in Asia-Pacific by 2025

Generative AI (GenAI) is projected to generate up to $100 billion in annual healthcare savings in Asia/Pacific excluding Japan (APEJ) by 2025, contributing to a potential 10% time release for clinicians. An IDC report indicates that by the end of 2027, 60% of healthcare organizations in the region will double their GenAI investments, driven by the demand for hyper-personalized patient experiences, improved collaboration, and equity in healthcare. GenAI is identified as a transformative force in the healthcare sector, impacting workforce efficiency and hyper-personalization in care processes.

The report also highlights a 60% increase in AI solution adoption by care providers in Asia/Pacific by 2026, driven by the need for enhanced diagnostic accuracy, speed, and workflow efficiency. Additionally, 50% of the healthcare industry in the region is expected to leverage GenAI by 2027 to address data and workflow fragmentation for improved diagnosis and patient safety, scaling care anywhere. The report emphasizes a 55% growth in investments in tech-enabled integrated care initiatives by 2026, addressing patient safety, workforce, and care access concerns in Asia/Pacific. Manoj Vallikkat, Senior Research Manager at IDC Asia/Pacific, emphasizes the significance of explainability and data security in managing the unique risks associated with AI in the healthcare sector.